Clene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. 

CEO
Robert Dee Etherington
CEORobert Dee Etherington
Employees
76
Employees76
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
76
Employees76

CLNN Key Statistics

Market cap
27.36M
Market cap27.36M
Price-Earnings ratio
-1.69
Price-Earnings ratio-1.69
Dividend yield
—
Dividend yield—
Average volume
73.56K
Average volume73.56K
High today
$3.49
High today$3.49
Low today
$2.89
Low today$2.89
Open price
$2.91
Open price$2.91
Volume
414.84K
Volume414.84K
52 Week high
$9.20
52 Week high$9.20
52 Week low
$2.57
52 Week low$2.57
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.